Basel Medical Group Ltd announced an initial public offering (IPO) on February 24, 2025, agreeing to sell 2,205,000 shares at $4.00 each, potentially raising $8,820,000 before expenses. The shares will begin trading under the ticker symbol 'BMGL' on February 25, 2025.